Liraglutide Attenuates Atorvastatin-Induced Hepatotoxicity by Restoring GLP-1R Expression and Activating Nrf2 and Autophagy Pathways in Wistar Rats
HMG-CoA reductase inhibitors, statins, are extensively used to treat hyperlipidemia, coronary artery disease, and other atherosclerotic disorders. However, one of the common side effects of statin therapy is a mild elevation in liver aminotransferases, observed in less than 3% of patients. Atorvasta...
Saved in:
Main Authors: | Engy A. Elsiad, Hayat A. Abd El Aal, Hesham A. Salem, Mohammed F. El-Yamany, Mostafa A. Rabie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Toxics |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6304/13/7/594 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compare the Decrease in Visceral Adipose Tissue in People with Obesity and Prediabetes vs. Obesity and Type 2 Diabetes Treated with Liraglutide
by: Rosa Nayely Hernández-Flandes, et al.
Published: (2025-07-01) -
Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment
by: Łukasz Zdziebkowski, et al.
Published: (2025-07-01) -
The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals
by: A. A. Andreev-Andrievsky, et al.
Published: (2025-08-01) -
The Potential Effect of Dapagliflozin and Liraglutide in Attenuating Cardio-Renal Injuries in Diabetic Rats
by: Albanna AA, et al.
Published: (2025-07-01) -
The effect of liraglutide on metabolic and reproductive outcomes in infertile women with PCOS: A prospective cohort study
by: Rossella Cannarella, et al.
Published: (2025-09-01)